This week, Claire and Gab unpack the stories shaping your body, your bank account, and even your AI therapist. Male Pill BreakthroughFor the first time, a non-hormonal male contraceptive has passed initial human trials. Could this finally shift the burden of birth control? We dig into the science, the trust issues, and why women might still keep a backup plan. Zara’s Thin Model Backlash & The Ozempic EffectZara’s UK ads have been banned for promoting unhealthy body standards—just as weight-loss drugs like Ozempic reshape not only fashion, but fine dining. From “heroin chic” to smaller plates at Michelin-starred restaurants, we explore how appetite-suppressing drugs are quietly changing industries. GPT-5 Breakup: Why Users Miss Their AI BestieA TikTok saga of a woman falling for her psychiatrist takes a turn when her ChatGPT bot “Henry” gets involved. But with GPT-5’s new, colder personality, users are mourning the loss of warmth from their favourite chatbot—and experts warn against relying on AI for therapy. Australia’s Housing Market Rort: The Underquoting CrisisEighty per cent of auctions are selling above the advertised price guide—and it’s not an accident. We unpack The Age’s investigation into underquoting, how buyers are being used as auction-day “props,” and why the real estate industry is finally hinting at reform. Plus: Justice for The Parent Trap’s Meredith Blake The Erin Patterson “Mushroom Lady” trial update Why smaller portion sizes might be the new normal If you’re into pop culture, media spin, and smart-but-fun takes on the week’s biggest stories, you’re in the right place. Subscribe, rate, and share SpinCycle—new episodes every week. Keywords: SpinCycle, Australian podcast, male contraception, male pill, Zara ad ban, heroin chic, Ozempic effect, GPT-5, ChatGPT therapy, AI relationships, underquoting, housing market Australia, Erin Patterson trial, Meredith Blake, Claire Anglim, Gabriella Bonanno, pop culture analysis, media spin